NIH Reporter #1R01HL180294-01

NHLBI Research Grant for Cardiovascular Inflammation in TB and HIV Survivors

This opportunity is a research grant solicitation from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), focused on cardiovascular inflammation in survivors of tuberculosis (TB) and HIV. - Government Buyer: - National Institutes of Health (NIH) - National Heart Lung and Blood Institute (NHLBI) - No specific Original Equipment Manufacturers (OEMs) or commercial vendors are named in the solicitation - Products/Services Requested: - Research services to study pulmonary and vascular inflammation in TB and HIV survivors - Characterization of clinical risk factors and inflammatory pathways - No physical products, part numbers, or purchase quantities specified - Notable Requirements: - Research must address excess cardiovascular inflammation in TB and HIV survivors - Focus on informing future treatment strategies - Grant classified under CFDA Code 93.838 (Infectious Diseases) - Total award amount is $2,513,201 - Open to applications via the standard NIH process - No unique license or classification requirements indicated

Description

This NIH research grant opportunity focuses on the role of pulmonary and vascular inflammation in TB and HIV survivors. The project aims to characterize clinical risk factors and inflammatory pathways to inform future treatment strategies. The goal is to reduce long-term cardiovascular morbidity and mortality among TB survivors. The award amount is $2,513,201 and it is a multiyear award. The solicitation is open for applications through the standard NIH application process.

View original listing